Bioventus price target raised to $18 from $14 at Barrington
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Barrington raises BVS target to $18; current price $15.26.
Target: $18
Posted price: $15.26
Analyst firm: Barrington
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.